about
Involvement of dopamine D2 receptor in the diurnal changes of tuberoinfundibular dopaminergic neuron activity and prolactin secretion in female ratsIn vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate.Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNODopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive taskImaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?Test-retest reproducibility of [11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm.Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNO.Dopamine receptor mapping with PET imaging in Parkinson's disease.The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding.Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
P2860
Q33603752-65E712C8-0E16-4DDF-92B7-D57D6055D11FQ33904670-018DC95B-48C2-44D4-8506-2D7BE1DD5C43Q34356950-CC871198-68A9-4B56-8042-113CA36D1CEEQ36636329-3125DFDA-A814-4B61-B4EA-7BE31467C8CCQ36723314-BFCAEFBF-9FF9-4045-B026-E2528493C005Q36976960-6F033A8E-89DE-47AC-8642-7429F32E549DQ37662436-840703DA-E249-4EAB-BD4F-1C8273858FCAQ38195788-C8A09E43-843B-40B3-A8AE-2AE0B9CFC2E0Q38650497-DF870546-76E8-41CA-8CD8-29BFFF05E708Q39656985-D893FCF7-0CA1-4775-937E-4D77858FE51CQ41993350-B0478719-8496-40FD-920F-80671435481FQ46157390-33B3E854-B8AD-4B99-9F1E-8BC86C68746CQ48588059-2606178B-C360-4D89-9232-33844CFC59BAQ48875088-238DAF55-E535-4601-822F-4A12BE864FC4
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Dopamine receptors labelled by PHNO.
@ast
Dopamine receptors labelled by PHNO.
@en
Dopamine receptors labelled by PHNO.
@nl
type
label
Dopamine receptors labelled by PHNO.
@ast
Dopamine receptors labelled by PHNO.
@en
Dopamine receptors labelled by PHNO.
@nl
prefLabel
Dopamine receptors labelled by PHNO.
@ast
Dopamine receptors labelled by PHNO.
@en
Dopamine receptors labelled by PHNO.
@nl
P2093
P356
P1433
P1476
Dopamine receptors labelled by PHNO.
@en
P2093
P2860
P304
P356
10.1002/SYN.890140403
P577
1993-08-01T00:00:00Z